Hemostatic changes in patients with brain tumors Journal Article


Authors: Thoron, L.; Arbit, E.
Article Title: Hemostatic changes in patients with brain tumors
Abstract: Abnormal hemostasis is a functional property of cancer. Hemostatic abnormalities are common in patients with systemic malignant disease and brain tumors. However, the incidence of thromboembolism is higher in patients with brain tumors than in those with systemic disease. This raises the question of whether or not hemostatic abnormalities found in the blood of the two groups of patients differs, suggesting different pathogeneses. The purpose of this report is to review abnormalities in blood and clinical manifestations of abnormal hemostasis found in brain tumors and cancer patients in an attempt to answer this question. Normal hemostasis, as currently understood, will be considered with an emphasis on features unique to the central nervous system. © 1994 Kluwer Academic Publishers.
Keywords: review; cancer radiotherapy; brain tumor; brain neoplasms; neoplasms; thrombocyte; brain cancer; blood clotting disorder; tissue plasminogen activator; partial thromboplastin time; tumor necrosis factor; coagulation; urokinase; hemostasis; interleukin 1; thromboplastin; blood clotting; blood coagulation; fibrinolysis; disseminated intravascular coagulation; von willebrand factor; disseminated intravascular clotting; cancer; human
Journal Title: Journal of Neuro-Oncology
Volume: 22
Issue: 2
ISSN: 0167-594X
Publisher: Springer  
Date Published: 1994-06-01
Start Page: 87
End Page: 100
Language: English
DOI: 10.1007/bf01052885
PROVIDER: scopus
PUBMED: 7745471
DOI/URL:
Notes: Export Date: 14 January 2019 -- Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ehud   Arbit
    66 Arbit